HPA Bylaws

Bylaws

• Schedule A - Code of Ethics
  • Code of Ethics - Summary of Standards
  • Code of Ethics - Detailed
  • Conflict of Interest Standards
  • Model for Ethical Decision Making
  • Patient Relations Program Standard
  • Pharmacy Oath
• Schedule B - Electoral Districts
• Schedule C - Recognized Education Programs
• Schedule D - Fee Schedule
• Schedule E - Tariff of Costs
• Schedule F - Standards of Practice
  • Part 1 - Community Pharmacy
  • Part 2 - Hospital Pharmacy
  • Part 3 - Residential Care Facilities and Homes
  • Part 4 - Drug Administration by Injection and Intranasal Route
  • Part 5 - Dispensing Drugs for the Purpose of Medical Assistance in Dying
  • Part 6 - Telepharmacy
  • Part 7 - Indigenous Cultural Safety, Humility, and Anti-racism Practice Standard
  • Part 8 - Making a Diagnosis and Prescribing
  • Part 9 - Ordering, Receiving, and Interpreting Laboratory Tests  Standards, Limits and Conditions
• Schedule G - Maximum Fees of the Freedom of Information and Protection of Privacy Act

PODSA Bylaws

• Bylaws
  • Schedule A - Fee Schedule
  • Schedule B - Exemptions to Act
  • Schedule F - Telepharmacy and Community Licenced Sites
  • Schedule G - Telepharmacy Staff Exempted Sites
  • Schedule H - Telepharmacy Rural and Remote Communities

Professional Practice Policies (Full Document)

GENERAL PHARMACY PRACTICE

• PPP-3 Pharmacy References
• PPP-58 Adapting a Prescription
• PPP-59 Pharmacy Equipment
• PPP-60 Professional Liability Insurance
• PPP-64 Guidelines to Pharmacy Compounding
• PPP-65 Narcotic Counts and Reconciliations
• PPP-68 Cold Chain Management
• PPP-70 Making a Diagnosis and Prescribing - Regulatory Education Module
• PPP-73 Validate Identification and Verify College Registration Status for New and Existing Registrant Staff
• PPP-75 Patient Identification
• PPP-76 Criminal Record History Vendor
• PPP-77 Signage within the Pharmacy (Expectations of Care Poster)

COMMUNITY PHARMACY

• PPP-15 Controlled Drug Substances Signing Authorizations
• PPP-24 Depot Shipments of Prescriptions
• PPP-31 Emergency Supply for Continuity of Care
• PPP-43 Automated Pharmacy Dispensing System
• PPP-46 Temporary Pharmacy Closures
• PPP-50 Centralized Prescription Processing
• PPP-54 Identifying Patients and Patient Representatives in Community Pharmacy and Telepharmacy Settings
• PPP-64 Guidelines to Pharmacy Compounding
• PPP-66 Opioid Agonist Treatment
• PPP-67 Injectable Opioid Agonist Treatment
• PPP-69 Community Pharmacy Manager Education
• PPP-71 Delivery of Opioid Agonist Treatment
• PPP-74 Community Pharmacy and Telepharmacy Security
• PPP-76 Criminal Record History Vendor
• PPP-77 Signage within the Pharmacy (Expectations of Care Poster)

HOSPITAL PHARMACY

• PPP-15 Narcotic and Controlled Drug Signing Authorizations
• PPP-27 Registration Requirements for Pharm.D. Program Students
• PPP-43 Automated Pharmacy Dispensing System
• PPP-56 Standards for Pharmacy Assistant Verification of Non-Sterile Products in Hospital Pharmacy Practice
• PPP-57 Standards for Pharmacy Assistant Verification of Sterile Products in Hospital Pharmacy Practice
• PPP-63 Hospital Pharmacist Role with Respect to Drug Distribution Systems, Drug Administration Devices, Products and Services
• PPP-64 Guidelines to Pharmacy Compounding
• PPP-76 Criminal Record History Vendor
• PPP-77 Signage within the Pharmacy (Expectations of Care Poster)

 

Guides and additional Resources
PPP-58 Adapting a Prescription: Additional Resources
PPP-66 Opioid Agonist Treatment: PPP-66 Policy Guide: Buprenorphine/Naloxone Maintenance Treatment (2018) PPP-66 Policy Guide: Methadone Maintenance Treatment (2013) PPP-66 Policy Guide: Slow Release Oral Morphine Maintenance (SROM) Treatment (2018)
PPP-67 Injectable Opioid Agonist Treatment  PPP-67 Policy Guide: Injectable Hydromorphone Maintenance Treatment (2018)